Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations

Journal of Neuroimmunology

Volumn 272, Issue 1-2, 2014, Pages 67-75

  Shi, Changbin ^a   Shenkar, Robert ^a   Kinloch, Andrew ^a   Henderson, Scott G ^a   Shaaya, Mark ^a   Chong, Anita S ^a   Clark, Marcus R ^a   Awad, Issam A ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Antibody; Antigen; Cerebral cavernous malformations; Clonal expansion; IgG; Lymphocyte

Indexed keywords

CD20 ANTIGEN; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN G;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; CAVERNOUS HEMANGIOMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGGREGATION; CELL EXPANSION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLONAL VARIATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOMATIC MUTATION;

ANTIBODY; ANTIGEN; CEREBRAL CAVERNOUS MALFORMATIONS; CLONAL EXPANSION; IGG; LYMPHOCYTE;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; B-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; SINGLE-CHAIN ANTIBODIES; T-LYMPHOCYTES;

EID: 84902013388     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.04.016     Document Type: Article

References (40)

1. Bergametti F., Denier C., Labauge P., Arnoult M., Boetto S., Clanet M., Coubes P., Echenne B., Ibrahim R., Irthum B., Jacquet G., Lonjon M., Moreau J.J., Neau J.P., Parker F., Tremoulet M., Tournier-Lasserve E. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 2005, 76:42-51.
2. Bradley W.G. MR appearance of hemorrhage in the brain. Radiology 1993, 189:15-26.
3. Breij E.C., Brink B.P., Veerhuis R., van den Berg C., Vloet R., Yan R., Dijkstra C.D., van der Valk P., Bo L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 2008, 63:16-25.
4. Chan A.C., Drakos S.G., Ruiz O.E., Smith A.C., Gibson C.C., Ling J., Passi S.F., Stratman A.N., Sacharidou A., Revelo M.P., Grossmann A.H., Diakos N.A., Davis G.E., Metzstein M.M., Whitehead K.J., Li D.Y. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J. Clin. Invest. 2011, 121:1871-1881.
5. Chang A., Henderson S.G., Brandt D., Liu N., Guttikonda R., Hsieh C., Kaverina N., Utset T.O., Meehan S.M., Quigg R.J., Meffre E., Clark M.R. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J. Immunol. 2011, 186:1849-1860.
6. Chen Y., Zhu W., Bollen A.W., Lawton M.T., Barbaro N.M., Dowd C.F., Hashimoto T., Yang G.Y., Young W.L. Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery 2008, 62:1340-1349. (discussion 1349-1350).
7. Chyatte D., Bruno G., Desai S., Todor D.R. Inflammation and intracranial aneurysms. Neurosurgery 1999, 45:1137-1146. (discussion 1146-1137).
8. Denier C., Goutagny S., Labauge P., Krivosic V., Arnoult M., Cousin A., Benabid A.L., Comoy J., Frerebeau P., Gilbert B., Houtteville J.P., Jan M., Lapierre F., Loiseau H., Menei P., Mercier P., Moreau J.J., Nivelon-Chevallier A., Parker F., Redondo A.M., Scarabin J.M., Tremoulet M., Zerah M., Maciazek J., Tournier-Lasserve E. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 2004, 74:326-337.
9. Denier C., Labauge P., Bergametti F., Marchelli F., Riant F., Arnoult M., Maciazek J., Vicaut E., Brunereau L., Tournier-Lasserve E. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann. Neurol. 2006, 60:550-556.
10. Gault J., Sarin H., Awadallah N.A., Shenkar R., Awad I.A. Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery 2004, 55:1-16. (discussion 16-17).
11. Gault J., Sain S., Hu L.J., Awad I.A. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery 2006, 59:1278-1284. (discussion 1284-1275).
12. Guclu B., Ozturk A.K., Pricola K.L., Seker A., Ozek M., Gunel M. Cerebral venous malformations have distinct genetic origin from cerebral cavernous malformations. Stroke 2005, 36:2479-2480.
13. Kanematsu Y., Kanematsu M., Kurihara C., Tada Y., Tsou T.L., van Rooijen N., Lawton M.T., Young W.L., Liang E.I., Nuki Y., Hashimoto T. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke 2011, 42:173-178.
14. Laberge-le Couteulx S., Jung H.H., Labauge P., Houtteville J.P., Lescoat C., Cecillon M., Marechal E., Joutel A., Bach J.F., Tournier-Lasserve E. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 1999, 23:189-193.
15. Liquori C.L., Berg M.J., Siegel A.M., Huang E., Zawistowski J.S., Stoffer T., Verlaan D., Balogun F., Hughes L., Leedom T.P., Plummer N.W., Cannella M., Maglione V., Squitieri F., Johnson E.W., Rouleau G.A., Ptacek L., Marchuk D.A. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 2003, 73:1459-1464.
16. Magro C.M., Schaefer J.T., Waldman J., Knight D., Seilstad K., Hearne D. Terbinafine-induced dermatomyositis: a case report and literature review of drug-induced dermatomyositis. J. Cutan. Pathol. 2008, 35:74-81.
17. Maraire J.N., Awad I.A. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery 1995, 37:591-605.
18. McDonald D.A., Shenkar R., Shi C., Stockton R.A., Akers A.L., Kucherlapati M.H., Kucherlapati R., Brainer J., Ginsberg M.H., Awad I.A., Marchuk D.A. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum. Mol. Genet. 2011, 20:211-222.
19. McDonald D.A., Shi C., Shenkar R., Stockton R.A., Liu F., Ginsberg M.H., Marchuk D.A., Awad I.A. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke 2012, 43:571-574.
20. Odegard V.H., Schatz D.G. Targeting of somatic hypermutation. Nat. Rev. Immunol. 2006, 6:573-583.
21. Otten P., Pizzolato G.P., Rilliet B., Berney J. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie 1989, 35(82-83):128-131.
22. Owens G.P., Ritchie A.M., Burgoon M.P., Williamson R.A., Corboy J.R., Gilden D.H. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J. Immunol. 2003, 171:2725-2733.
23. Peitsch M.C., Tschopp J. Assembly of macromolecular pores by immune defense systems. Curr. Opin. Cell Biol. 1991, 3:710-716.
24. Plummer N.W., Gallione C.J., Srinivasan S., Zawistowski J.S., Louis D.N., Marchuk D.A. Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am. J. Pathol. 2004, 165:1509-1518.
25. Revencu N., Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J. Med. Genet. 2006, 43:716-721.
26. Rigamonti D., Drayer B.P., Johnson P.C., Hadley M.N., Zabramski J., Spetzler R.F. The MRI appearance of cavernous malformations (angiomas). J. Neurosurg. 1987, 67:518-524.
27. Robinson J.R., Awad I.A., Little J.R. Natural history of the cavernous angioma. J. Neurosurg. 1991, 75:709-714.
28. Robinson J.R., Awad I.A., Masaryk T.J., Estes M.L. Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery 1993, 33:547-554. (discussion 554-545).
29. Rowley A.H., Shulman S.T., Garcia F.L., Guzman-Cottrill J.A., Miura M., Lee H.L., Baker S.C. Cloning the arterial IgA antibody response during acute Kawasaki disease. J. Immunol. 2005, 175:8386-8391.
30. Sahoo T., Johnson E.W., Thomas J.W., Kuehl P.M., Jones T.L., Dokken C.G., Touchman J.W., Gallione C.J., Lee-Lin S.Q., Kosofsky B., Kurth J.H., Louis D.N., Mettler G., Morrison L., Gil-Nagel A., Rich S.S., Zabramski J.M., Boguski M.S., Green E.D., Marchuk D.A. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 1999, 8:2325-2333.
31. Scolding N.J., Morgan B.P., Houston W.A., Linington C., Campbell A.K., Compston D.A. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 1989, 339:620-622.
32. Shi C., Shenkar R., Batjer H.H., Check I.J., Awad I.A. Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. J. Neurosurg. 2007, 107:1023-1026.
33. Shi C., Shenkar R., Du H., Duckworth E., Raja H., Batjer H.H., Awad I.A. Immune response in human cerebral cavernous malformations. Stroke 2009, 40:1659-1665.
34. Steiger H.J., Markwalder T.M., Reulen H.J. Clinicopathological relations of cerebral cavernous angiomas: observations in eleven cases. Neurosurgery 1987, 21:879-884.
35. Tu J., Stoodley M.A., Morgan M.K., Storer K.P. Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations. J. Neurosurg. 2005, 103:903-909.
36. Tulamo R., Frosen J., Junnikkala S., Paetau A., Pitkaniemi J., Kangasniemi M., Niemela M., Jaaskelainen J., Jokitalo E., Karatas A., Hernesniemi J., Meri S. Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery 2006, 59:1069-1076. (discussion 1076-1067).
37. Vasil K.E., Magro C.M. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda. J. Am. Acad. Dermatol. 2007, 56:96-104.
38. Vymazal J., Brooks R.A., Baumgarner C., Tran V., Katz D., Bulte J.W., Bauminger R., Di Chiro G. The relation between brain iron and NMR relaxation times: an in vitro study. Magn. Reson. Med. 1996, 35:56-61.
39. Wong J.H., Awad I.A., Kim J.H. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery 2000, 46:1454-1459.
40. Xing G.Q., Chen M., Liu G., Heeringa P., Zhang J.J., Zheng X., E.J., Kallenberg C.G., Zhao M.H. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J. Clin. Immunol. 2009, 29:282-291.